Arcus Biosciences, Inc.
Industry: Life Sciences ・ $RCUS on NYSE
Insider Sale
+$40,080
-3.72%
Shares
Shares Volume: 2,004 Shares
Average Share Price: $20
INSIDER
Goeltz II Robert C.
Chief Financial Officer (Officer)
reported on Jan 4 2024
traded on Jan 2 2024
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 51,831 |
| PURCHASES/SALES 1Y | 0 / 2 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $60,610.98 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 1 / 11 |
| P/S VALUE RATIO | 7.384 |
| AVERAGE SALE VALUE | $239,508.75 |
| COMPANY PREVIOUS TRADES |